Finance
ACAD’s price-to-sales ratio: A comparative analysis with its peers
Acadia Pharmaceuticals Inc (ACAD)’s stock has witnessed a price declined of -18.09% from the previous close with its current price standing at $15.44. Its current
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.